Using nanotechnology to fight cancer

(Northwestern University) Northwestern University, a leader in cancer nanotechnology research, has received a five-year, $11.7 million grant from the National Cancer Institute to use nanotechnology to develop next-generation cancer treatments. The Northwestern University Center for Cancer Nanotechnology Excellence will use nucleic-acid-based nanoconstructs called Spherical Nucleic Acids to access intracellular environments, discover new aspects of cancer biology and create effective cancer treatment options. A focus will be on helping those suffering from glioblastoma multiforme and prostate cancer.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news

Related Links:

Publication date: Available online 16 August 2019Source: Inorganica Chimica ActaAuthor(s): Gisele dos S.S. Firmino, Stephanie C. André, Zandora Hastenreiter, Vanessa Karen Campos, Mostafa A.L. Abdel-Salam, Elaine M. de Souza-Fagundes, Josane A. LessaAbstractCancer cells have high iron demand to mediate their rapid proliferation. Aiming to obtain cytotoxic compounds with potential iron metabolism disturbance in malignant cells, [Ga(HAPIH)(APIH)](NO3)2⋅2H2O (1) and [Ga(HPAmIH)(PAmIH)](NO3)2⋅2H2O (2) were synthesized with the iron chelators 2-acetylpyridine- and 2-pyridineformamide isonicotinoyl hydrazone (HA...
Source: Inorganica Chimica Acta - Category: Chemistry Source Type: research
ConclusionsAdjuvant docetaxel without prednisone did not improve BDFS after radical RT with ADT for intermediate- or high-risk PCa.Patient summaryWe compared six cycles of adjuvant docetaxel given after radical external radiotherapy plus androgen deprivation therapy to surveillance in intermediate- and high-risk localised prostate cancer. We found no overall benefit in this setting.
Source: European Urology - Category: Urology & Nephrology Source Type: research
Publication date: Available online 20 August 2019Source: European UrologyAuthor(s): Alberto Donzelli, Gianluca Castelluzzo, Giulia Giudicatti
Source: European Urology - Category: Urology & Nephrology Source Type: research
In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps.MethodsFor this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to in...
Source: The Lancet - Category: General Medicine Source Type: research
Case Description: A 67-year-old male with history of adenosquamous prostate cancer status post prostatectomy, cystectomy, diverting loop colostomy with urostomy, leuprolide, and radiation was recently started on chemotherapy with docetaxel. He presented to emergency room 3 days after his first docetaxel infusion with complains of fever, nausea, and skin rash in bilateral axillae, and arms. The rash was mildly pruritic and painful. The patient had a recent episode of mild sunburn a week prior to his infusion, which had completely resolved before infusion.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
An 82-year-old man with a history of prostate cancer presented with several months of enlarging ulcerated tumors and nodules on the upper and lower extremities. The patient had numerous tumors>7 cm in diameter, including a large grouping of 5-6 on his left anterior thigh, a cobblestone plaque on the right posterior calf, and innumerable discrete nodules on the bilateral forearms. Punch biopsy was performed and revealed a dense dermal nonepidermotropic infiltrate of neoplastic CD3+ CD4+ CD30- T cells with convoluted cerebriform nuclei.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
Condition:   Prostatic Adenocarcinoma Intervention:   Sponsor:   University Hospital, Brest Recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Prostate Cancer Screening;   Prostate Cancer Interventions:   Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Prostate-specific antigen (PSA) test Sponsors:   University College, London;   Medical Research Council;   Cancer Research UK;   Imperial College London;   King's College London Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Publication date: 20 August 2019Source: Cell Reports, Volume 28, Issue 8Author(s): Diletta Di Mitri, Michela Mirenda, Jelena Vasilevska, Arianna Calcinotto, Nicolas Delaleu, Ajinkya Revandkar, Veronica Gil, Gunther Boysen, Marco Losa, Simone Mosole, Emiliano Pasquini, Rocco D’Antuono, Michela Masetti, Elena Zagato, Giovanna Chiorino, Paola Ostano, Andrea Rinaldi, Letizia Gnetti, Mariona Graupera, Ana Raquel Martins Figueiredo FonsecaSummaryTumor-associated macrophages (TAMs) represent a major component of the tumor microenvironment supporting tumorigenesis. TAMs re-education has been proposed as a strategy to promote...
Source: Cell Reports - Category: Cytology Source Type: research
Authors: Liu J, Li Y, Yang D, Yang C, Mao L Abstract In recent years, with the westernization of lifestyle, reduced physical activity and increased prostate-specific antigen (PSA) testing, the incidence of prostate cancer (PCa) has risen significantly in developing countries. Currently, PSA is the only PCa biomarker applied clinically, but it does not perform well in the early diagnosis and distinguishing between benign prostatic hyperplasia and prostate cancer. With the advances in deep sequencing technology, a series of new PCa biomarkers have been recently proposed to improve the diagnostic value of PSA, such as...
Source: Discovery Medicine - Category: Research Tags: Discov Med Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Environmental Health | Grants | Health | International Medicine & Public Health | Nanotechnology | Prostate Cancer